English
Structure via PubChem · Public domain (PubChem)
nelivaptan
Sign in to saveAlso known as SSR-149,415, SSR149415
Nelivaptan (INN) (developmental codename SSR-149,415) is a selective, orally active, non-peptide vasopressin receptor antagonist selective for the V1B subtype. The drug had entered clinical trials for treatment of anxiety and depression. In July 2008, Sanofi-Aventis announced that further development of this drug had been halted.
In the Vinony graph
Within Vinony's link graph, nelivaptan is referenced by 64 other articles, and connects out to arginine vasopressin, oral administration and World Health Organization.
Vinony files it under Abandoned drugs, Chemical pages without DrugBank identifier and Drugboxes which contain changes to verified fields.
Its subject is documented across 5 Wikipedia language editions.
Chemical data
- Formula
- C30H32ClN3O8S
- Molecular weight
- 630.1 g/mol
- IUPAC name
- (2S,4R)-1-[(3R)-5-chloro-1-(2,4-dimethoxyphenyl)sulfonyl-3-(2-methoxyphenyl)-2-oxoindol-3-yl]-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide
- SMILES
- CN(C)C(=O)[C@@H]1C[C@H](CN1[C@]2(C3=C(C=CC(=C3)Cl)N(C2=O)S(=O)(=O)C4=C(C=C(C=C4)OC)OC)C5=CC=CC=C5OC)O
- InChIKey
- NJXZWIIMWNEOGJ-WEWKHQNJSA-N
- XLogP
- 3.4
- Polar surface area
- 134 Ų
- H-bond donors
- 1
- H-bond acceptors
- 9
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- anxiety, depressive disorder
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 629.16
Show 3 more facts
- chemical formula
- C₃₀H₃₂ClN₃O₈S
- isomeric SMILES
- CN(C)C(=O)[C@@H]1C[C@H](CN1[C@]2(C3=C(C=CC(=C3)Cl)N(C2=O)S(=O)(=O)C4=C(C=C(C=C4)OC)OC)C5=CC=CC=C5OC)O
- canonical SMILES
- CN(C)C(=O)C1CC(CN1C2(C3=C(C=CC(=C3)Cl)N(C2=O)S(=O)(=O)C4=C(C=C(C=C4)OC)OC)C5=CC=CC=C5OC)O
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
3 sectionsContents
- See also
- References
- External links
Nelivaptan (INN) (developmental codename SSR-149,415) is a selective, orally active, non-peptide vasopressin receptor antagonist selective for the V1B subtype. The drug had entered clinical trials for treatment of anxiety and depression. In July 2008, Sanofi-Aventis announced that further development of this drug had been halted.
==See also== ABT-436 Balovaptan SRX-246 TS-121
Excerpted from Wikipedia’s “nelivaptan” article, available under the CC BY-SA 4.0 licence.